Precision Medicine in Chronic Lymphocytic Leukemia (CLL)
Join us for a discussion with Prof Paolo Ghia, MD, PhD, from Università Vita Salute San Raffaele, Milan (Italy), as he explores how precision medicine is transforming CLL treatment.
In this episode, discover how precision medicine is used daily in CLL to decide the best management and treatment for patients. Listen to Prof Ghia explain how CLL management is moving from traditional chemotherapy to targeted therapies based on specific genetic markers, like immunoglobulin mutational status or P53 aberrations, which help guide treatment decisions.
Explore the array of targeted therapies available…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.